Response of chordoma cell lines to treatment with the KIF18A inhibitor sovilnesib (AMG 650), as a single agent and in combination with gemcitabine
<p dir="ltr">To evaluate KIF18A inhibitors as a potential therapeutic target, chordoma cell lines were treated with sovilnesib. A panel of four chordoma cell lines was seeded in a white-walled 96-well plate so that, at the start of treatment (36 hours after plating), the confluence w...
Saved in:
| Main Author: | |
|---|---|
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|